Terns Pharmaceuticals, Inc.
TERN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $342 | $252 | $505 |
| - Cash | $151 | $146 | $139 | $161 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | – | $197 | $115 | $345 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$25 | -$24 | -$27 | -$26 |
| % Margin | – | – | – | – |
| Net Income | -$25 | -$24 | -$24 | -$22 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.27 | -0.26 | -0.26 | -0.24 |
| % Growth | -3.8% | 0% | -8.3% | – |
| Operating Cash Flow | -$20 | -$19 | -$24 | -$15 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$20 | -$19 | -$24 | -$15 |